JP2023526505A5 - - Google Patents
Info
- Publication number
- JP2023526505A5 JP2023526505A5 JP2022571179A JP2022571179A JP2023526505A5 JP 2023526505 A5 JP2023526505 A5 JP 2023526505A5 JP 2022571179 A JP2022571179 A JP 2022571179A JP 2022571179 A JP2022571179 A JP 2022571179A JP 2023526505 A5 JP2023526505 A5 JP 2023526505A5
- Authority
- JP
- Japan
- Prior art keywords
- intracellular calcium
- calcium signaling
- signaling inhibitor
- pyrazole
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063027800P | 2020-05-20 | 2020-05-20 | |
| US63/027,800 | 2020-05-20 | ||
| PCT/US2021/033237 WO2021236820A1 (en) | 2020-05-20 | 2021-05-19 | Methods and compositions for treating acute kidney injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023526505A JP2023526505A (ja) | 2023-06-21 |
| JP2023526505A5 true JP2023526505A5 (enExample) | 2024-05-27 |
Family
ID=76444616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022571179A Pending JP2023526505A (ja) | 2020-05-20 | 2021-05-19 | 急性腎障害を治療するための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230226058A1 (enExample) |
| EP (1) | EP4153179A1 (enExample) |
| JP (1) | JP2023526505A (enExample) |
| CN (1) | CN116261468A (enExample) |
| AU (1) | AU2021273811A1 (enExample) |
| CA (1) | CA3179405A1 (enExample) |
| WO (1) | WO2021236820A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10703722B2 (en) | 2010-04-27 | 2020-07-07 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| TWI771269B (zh) | 2015-02-27 | 2022-07-21 | 美商鈣系醫藥公司 | 胰腺炎治療 |
| CA3172249A1 (en) | 2020-03-20 | 2021-09-23 | Calcimedica, Inc. | Methods and compositions for treating acute lung injury and acute respiratory distress syndrome |
| JP7791898B2 (ja) | 2020-11-13 | 2025-12-24 | カルシメディカ，インク． | Ｃｒａｃチャネル阻害剤の合成の改善 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078995A2 (en) | 2003-03-04 | 2004-09-16 | Neurogenetics, Inc. | Methods of modulating and of identifying agents that modulate intracellular calcium |
| EP1984400B1 (en) | 2006-01-05 | 2012-11-28 | Immune Disease Institute, Inc. | Regulators of nfat |
| CN107207431B (zh) * | 2015-01-13 | 2021-02-09 | 维夫雷昂生物科学有限责任公司 | Ca2+释放激活的Ca2+(CRAC)通道的调节剂及其药物用途 |
| TWI771269B (zh) * | 2015-02-27 | 2022-07-21 | 美商鈣系醫藥公司 | 胰腺炎治療 |
| US20210338630A1 (en) * | 2018-10-04 | 2021-11-04 | The Trustees Of Indiana University | Methods to treat renal disorders using calcium channel inhibitors |
-
2021
- 2021-05-19 CN CN202180059383.8A patent/CN116261468A/zh active Pending
- 2021-05-19 AU AU2021273811A patent/AU2021273811A1/en active Pending
- 2021-05-19 JP JP2022571179A patent/JP2023526505A/ja active Pending
- 2021-05-19 EP EP21732700.6A patent/EP4153179A1/en active Pending
- 2021-05-19 CA CA3179405A patent/CA3179405A1/en active Pending
- 2021-05-19 WO PCT/US2021/033237 patent/WO2021236820A1/en not_active Ceased
-
2022
- 2022-11-18 US US18/056,973 patent/US20230226058A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023528537A5 (enExample) | ||
| JP2012515787A5 (enExample) | ||
| JP2012515788A5 (enExample) | ||
| JP2023504415A5 (enExample) | ||
| JP2006517939A5 (enExample) | ||
| JP2010504280A5 (enExample) | ||
| JP2006516251A5 (enExample) | ||
| JP2009529059A5 (enExample) | ||
| JP2009511450A5 (enExample) | ||
| RU2013130879A (ru) | Производные оксазолилметилового эфира в качестве агонистов рецептора alx | |
| AU2021239361A1 (en) | Methods and compositions for treating acute lung injury and acute respiratory distress syndrome | |
| US20230226058A1 (en) | Methods and compositions for treating acute kidney injury | |
| JP2014523400A (ja) | 芳香族アミド類およびそれらの使用 | |
| JP2009532438A5 (enExample) | ||
| RU2017105902A (ru) | Соединения для применения в дегельминтизации | |
| JP2013544811A5 (enExample) | ||
| JP2020531425A5 (enExample) | ||
| JP2007538064A (ja) | 化学または生物兵器に曝露された患者を処置するための肥満細胞阻害剤の使用法 | |
| CN110573148A (zh) | 特发性肺纤维化的治疗 | |
| RU2013103746A (ru) | КОМБИНАЦИЯ, ВКЛЮЧАЮЩАЯ A)НИЛОТИНИБ, Б)ИНГИБИТОР КИНАЗЫ Тhr315lle | |
| JP2010526051A5 (enExample) | ||
| US20250120969A1 (en) | Methods and compositions for treating inflammation injury in the lungs | |
| JP2023522693A5 (enExample) | ||
| CA2433409A1 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| JP2019515003A5 (enExample) |